213-384-1

应用筛选条件

关键词:'213-384-1'

显示 1-23 共 23 条结果关于 "213-384-1" 范围技术文档

Highly sensitive and specific 384 well assay for chemiluminescent detection of cyclic AMP

- response CHO wt cells were seeded at 10,000 cells per well in a 384-well plate 24 hr before the assay. Cells were pre-incubated with 1 mM IBMX for 5 minutes, then various concentrations of forskolin were

Quality Control Range Sheet- MTH17-113 and MTH17-213

Analyte QC Level Expected Range Units IL-25/IL-17E Control 1 6937– 14407 pg/mL IL-21 Control 1 145 – 344 pg/mL IL-17A Control 1 384 – 797 pg/mL Control 2 27761 – 65482 pg/mL

cAMP HTS Immunoassay Kit, 384 well, 5X (Chemiluminescent)

Instructions 1. Equilibrate assay reagents to room temperature before use. 2. Remove White 384-Well anti-Rabbit Coated Plate/s from foil pouch. 3. Add 30 µL of cAMP Standards 1 through 8

cAMP HTS Immunoassay Kit, 384 well (Chemiluminescent)

Instructions 1. Equilibrate assay reagents to room temperature before use. 2. Remove White 384-Well anti-Rabbit Coated Plate/s from foil pouch. 3. Add 30 μL of cAMP Standards 1 through 8

XP725 Antibody Number-Lot Number 071M4826

335 336 357 358 359 360 381 382 383 384 XP725 Antibody Number—Lot Number 071M4826 A B C D a-b c-d e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h 1.1 1 2

Data Sheet - M8567

Kähäri, V.M., and Saarialho-Kere, U., Matrix metalloproteinases in skin. Exp. Dermatol., 6, 199-213 (1997). 4. Parks, W.C., and Mecham, R.P., Matrix metalloproteinases. Academic Press (1998).

Data Sheet - M8692

Kähäri, V.M., and Saarialho-Kere, U., Matrix metalloproteinases in skin. Exp. Dermatol., 6, 199-213 (1997). 4. Parks, W.C., and Mecham, R.P., Matrix metalloproteinases. Academic Press (1998).

Data Sheet - M8442

Kähäri, V.M., and Saarialho-Kere, U., Matrix metalloproteinases in skin. Exp. Dermatol., 6, 199-213 (1997). 4. Parks, W.C., and Mecham, R.P., Matrix metalloproteinases. Academic Press (1998).

Data Sheet - M8817

Kähäri, V.M., and Saarialho-Kere, U., Matrix metalloproteinases in skin. Exp. Dermatol., 6, 199-213 (1997). 4. Parks, W.C., and Mecham, R.P., Matrix metallo- proteinases. Academic Press (1998).

App. Note Detection of pyrogens in hormone-based drugs

in ovarian stimulation for assisted reproduction? Women’s Heal. 2, 375–384 (2006). 20. Low Endotoxin Recovery (LER): A Review. 1–8 (2014). 21. Williams (Lonza), K. L. Low Endotoxin Recovery (LER)

Product Information Sheet - HPFM2

Wilms tumor 1 7490 ZNF198 zinc fi nger protein 198 7750 ZNF278 zinc fi nger protein 278 23598 ZNF384 zinc fi nger protein 384 171017 ZNFN1A1 zinc fi nger protein subfamily 1A 1 (Ikaros) 10320

XP725 Antibody List Lot 129K4831

Cathepsin D C0715 1509 CTSD M NP_001900.1 y n/d n/d 146 Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y 213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d 214

XP725 Antibody List Lot 129K4830

Cathepsin D C0715 1509 CTSD M NP_001900.1 y n/d n/d 146 Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y 213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d 214

XP725 Antibody List Lot 089K4791

Cathepsin D C0715 1509 CTSD M NP_001900.1 y n/d n/d 146 Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y 213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d 214

List of Antibodies

18 C1399 M y n/d n/d 211 Cytokeratin peptide 19 C6930 M y n/d n/d 212 Pan Cytokeratin P2871 M y y y 213 DAPK D2178 M y n/d n/d 214 phospho-DAPK (pSer308) D4941

inNovations Newsletter #17

. REFERENCES 1. Mills, I. G., Praefcke, G. J., Vallis, Y., Peter, B. J., Olesen, L. E., Gallop, J. L., Butler, P. J., Evans, P. R., and McMahon, H. T. (2003) J. Cell Biol. 160, 213–222. 2. Dong

XP725 Antibody List

Cytokeratin peptide 19 C6930 3880 KRT19 NP_002267.2 M y n/d n/d 212 Pan Cytokeratin P2871 M y y y 213 DAPK D2178 1611 DAP NP_004385.1 M y n/d n/d 214 phospho-DAPK (pSer308) D4941

XP725 Antibody List 013M4793

Cytokeratin peptide 19 C6930 3880 KRT19 NP_002267.2 M y n/d n/d 212 Pan Cytokeratin P2871 M y y y 213 DAPK D2178 1611 DAP NP_004385.1 M y n/d n/d 214 phospho-DAPK (pSer308) D4941

Cytoskeletal Signaling Antibodies, Reagents and Kits

.a. 1223-1290 H R IP WB Pur Rb 100 µg AB3882 Anti-phospho-mTOR (Ser2448) M WB APur Rb 100 µg 09-213 siRNA siRNA plasmid, pKD-mTOR-v4, H RNAi 5 mg 62-302 see also GβL, Raptor, Rheb, Sin1 and

Halal Certificate

B23379 HC-23SI1J13 212. 3-(METHYLTHIO)PROPYL ISOTHIOCYANATE 98%, FG W331201 A32483 HC-23SIE869 213. 3,4-DIMETHYL-1,2-CYCLOPENTADIONE 97% W326801 B59475 HC-23SIHC55 214. 3,4-HEXANEDIONE 90% W316814

Halal Certificate

B23379 HC-22SI7U34 212. 3-(METHYLTHIO)PROPYL ISOTHIOCYANATE 98%, FG W331201 A32483 HC-22SI1Z90 213. 3,4-DIMETHYL-1,2-CYCLOPENTADIONE 97% W326801 B59475 HC-22SIDD76 214. 3,4-HEXANEDIONE 90% W316814

XP725 Worksheet for Lot Number 071M4826

CaMKIV C2851 212 2 1 3 4 CaM Kinase IV CaMKIV C2851 213 2 1 3 5 CaM Kinase Kinase a CaMKKa C7099 CaM Kinase Kinase a CaMKKa C7099214 2 1 3 6 215 2 1 3 7 CaM Kinase IIa C6974 216

Brochure: Chromolith® Monolithic Silica HPLC Columns for small and large molecule separation

Column temp.: ambient Injection volume: 1 μL Detector: UV, 282 nm Sample: 2,4,5-Trihydroxyphenylalanine 4 μg/mL, Levodopa 402 μg/mL, Methyldopa 384 μg/mL, Dopamine 217 μg/mL, Carbidopa 232 μg